Tradestie Institutional Equity Comparison Engine

ABCL vs FRDU โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ABCL Overall Edge

ABCL Captures Institutional Edge (3โ€“1 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to AbCellera Biologics Inc. Common Shares (ABCL) driven by superior Valuation, Growth & Margin, Momentum & Technical while FRDU counters with relative strength in Options & Structure. Fundamentally, ABCL trades at 27.6x Forward P/E with -298.0% operating margin (+18.8% YoY revenue) versus FRDU at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ABCL sits in BREAKDOWN (32nd %ile IV; Dealer Gamma Walls on Pro) against FRDU sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ABCL
ABCL 27.6x vs FRDU N/M Fwd P/E
Growth & Margin Winner ABCL
Op Margin -298.0% vs N/A ยท YoY +18.8% vs N/A
Momentum & Technical Winner ABCL
1Y +168.4% vs +2.7% ยท 52W Pos 57% vs 20%
Options & Structure Winner FRDU
BREAKDOWN (32nd %ile IV) vs UNCLASSIFIED (N/A IV)
ABCL NASDAQ
AbCellera Biologics Inc. Common Shares
Pharmaceutical Preparations
$9.69
-7.45% 1D
Market Cap $3.4B
1M Return -14.78%
1Y Return +168.42%
Forward P/E 27.6x
Unified AI Score
57.1 / 100 HOLD
Tech 33.0 Fund 54.0 Flow 70.0 Mom 64.0
FRDU US Equity
FRDU
Institutional Equity
$26.54
-2.29% 1D
Market Cap N/A
1M Return -2.37%
1Y Return +2.66%
Forward P/E N/M
Unified AI Score
54.6 / 100 HOLD
Tech 60.0 Fund 57.0 Flow 50.0 Mom 59.2

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ABCL +168.42% FRDU +2.66% Spread: +15.87 pp (ABCL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ABCL TTM Op. Margin: -298.0% FRDU TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABCL vs FRDU. Trailing 12-month operating profitability (ABCL -298.0% vs FRDU N/A) and valuation multiples (ABCL 27.6x vs FRDU N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ABCL (9) vs FRDU (1)
Institutional Metric ABCL FRDU Criterion Row Winner
Market Capitalization Scale $3.4B N/A Larger Scale ABCL
Trailing P/E Ratio Valuation 27.6x N/M Lower Multiple ABCL
Forward P/E Ratio Valuation 27.6x N/M Lower Multiple ABCL
Revenue Growth (YoY) Growth +18.8% N/A Higher Growth ABCL
Operating Margin (TTM) Profitability -298.0% N/A Higher Margin ABCL
Net Profit Margin Profitability -218.6% N/A Higher Margin ABCL
Return on Equity (ROE) Capital Efficiency -14.6% N/A Higher ROE ABCL
52-Week Range Position Momentum 57% ($3โ€“$15) 20% ($23โ€“$41) Stronger Trend ABCL
Beta / 30D Volatility Risk Regime 2.32ฮฒ ยท 85% Vol 2.29ฮฒ ยท 62% Vol Lower Realized Risk FRDU
Unified Institutional Score Composite Signal 57.1 / 100 (HOLD) 54.6 / 100 (HOLD) Higher Composite ABCL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ABCL vs FRDU Buy Guide
ABCL BREAKDOWN
38d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 32nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ABCL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
FRDU UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live FRDU Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ABCL nor FRDU registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.